Search clinical trials for: Camostat+Mesilate

Total 1418 results

Cancer Research UK
Latus Therapeutics

Terminated

A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1) (SPIKE-1)

COVID-19 Infection

United Kingdom
Sagent Pharmaceuticals Inc.

Completed

Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)

COVID-19

United States
Yale University

Completed

Camostat Mesylate in COVID-19 Outpatients

COVID-19

United States
Heinrich-Heine University, Duesseldorf
The Federal Ministry of Health, Germany (Bundesministerium für Gesundheit...

Completed

Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals (RES-Q-HR)

Corona Virus Infection | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS-CoV-2 PCR Test Positive

Germany
Yale University
Ono Pharmaceutical Co. Ltd

Withdrawn

The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications

COVID-19 | Coagulopathy | Cardiovascular Complication
Seoul National University Hospital

Not yet recruiting

Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation

Fontan Operation | Protein-Losing Enteropathy | Camostat Mesylate
Assistance Publique - Hôpitaux de Paris

Terminated

CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients (CAMOVID)

Covid19

France
Alan Bryce

Unknown

Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 (RECOVER)

Severe Acute Respiratory Syndrome

United States
Stanford University

Completed

Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients (COPS-2003)

Covid19

United States
University of Aarhus

Recruiting

The Impact of Camostat Mesilate on COVID-19 Infection (CamoCO-19)

Corona Virus Infection

Denmark, Sweden
Heinrich-Heine University, Duesseldorf
Universitätsklinikum Hamburg-Eppendorf; University Hospital Frankfurt; St. Georg... and other collaborators

Withdrawn

Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19 (CLOCC)

COVID
Instituto Nacional de Ciencias Medicas y Nutricion...

Terminated

Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients

Hypertension | Obesity | Diabetes | Covid19

Mexico
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Camostat With Bicalutamide for COVID-19 (COMBO)

Coronavirus Infection | Covid19 | SARS-CoV Infection

United States
Eisai Limited

Completed

An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid Tumors

Solid Tumors

United Kingdom
Susanne Arnold

Terminated

Novel Agents for Treatment of High-risk COVID-19 Positive Patients

COVID | Sars-CoV2

United States
Opiant Pharmaceuticals Inc

Completed

Pharmacodynamic Evaluation of Intranasal Nalmefene

Pharmacodynamic

United States
Sheba Medical Center

Unknown

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus (COSTA)

COVID - 19

Israel
Augusta University

Completed

Rectal Sensory Training - A Study of Two Techniques

Constipation | Rectal Hyposensitivity

United States
Mayo Clinic

Withdrawn

Sensorimotor Dysfunction in Achalasia

Achalasia

United States
Ospedale Regina Apostolorum
Azienda Ospedaliera San Gerardo di Monza; San Giuseppe Moscati Hospital; Ospedali...

Unknown

Demonstrate the Effectiveness to Hemopatch in Controlling Postoperative Bleeding After Laparoscopic Cholecistectomy and in Reducing of Morbidity and Postoperative Hospital Stay

Efficacy of Hemopatch in Controlling of Postoperative Bleeding or Reducing of Postperative Morbidity After Laparoscopic Cholecistectomy

Italy
University of Zurich

Completed

Short Protocol Barostat for Assessment of Anorectal Function Versus Standard Protocol Barostat in Healthy Volunteers

Healthy

Switzerland
National Institute of Diabetes and Digestive and...

Completed

Clinical Approaches to Ileal Pouch Dysfunction

Pouchitis

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaborators

Completed

ACTIV-2: A Study for Outpatients With COVID-19

Covid19 | Coronavirus

United States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
University of Bologna

Completed

Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase

Myeloid Leukemia, Chronic, Chronic-Phase

Italy
International Centre for Diarrhoeal Disease Research...
Grand Challenges Canada; Dhaka Medical College; Jibon Health Technologies, Inc.; Shaheed Suhrawardi Medical College Hospital

Terminated

Tampostat for Management of Postpartum Hemorrhage

Postpartum Hemorrhage

Bangladesh
Novartis Pharmaceuticals

Completed

Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors

Refractory Desmoplastic Small Round Cell Tumors

Italy
Quirón Madrid University Hospital
Baxter BioScience

Completed

SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial Using HEMOPATCH

LUNG DISEASES

Spain
RedHill Biopharma Limited

Suspended

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

Covid19

United States, South Africa
Charité Research Organisation GmbH
Bayer

Terminated

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat (NICCAM)

Covid19

Germany
Chengdu Zenitar Biomedical Technology Co., Ltd

Completed

Study of Prilinostat Mesylate for Injection in the Treatment of Relapsed or Refractory B Cell-related Tumor-predominant

Diffuse Large B Cell Lymphoma，DLBCL

China
Centre Leon Berard

Completed

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)

Gastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene Mutation

France
Abyrx, Inc.

Terminated

Clinical Investigation of MONTAGE in Adults With Spinal Deformity Undergoing Pedicle Subtraction Osteotomy

Ankylosing Spondylitis | Fused Vertebrae | Sagittal Deformities | Thoracolumbar Kyphosis

United States
Instituto Grifols, S.A.

Completed

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries

Parenchymous Tissue Surgical Bleeding

United States, Hungary, Russian Federation, Serbia
Fudan University

Unknown

Use of an Oxidized Regenerated Cellulose After Hepatic Surgery

Liver Neoplasms

China
Swiss Group for Clinical Cancer Research

Terminated

Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer

Adenocarcinoma | Breast Cancer

Switzerland
Tianjin Chasesun Pharmaceutical Co., LTD
Southwest Hospital, China

Completed

Phase I Study of Kukoamine B Mesilate in Healthy Volunteers

Healthy

China
Medical University of Vienna

Unknown

Hemopatch for Prevention of Bile Leaks After Liver Resection

Bile Leak

Austria
IlDong Pharmaceutical Co Ltd

Completed

A Phase I Study of IDP-73152 Mesylate in Health Male Volunteer (PDF inhibitor)

Healthy

Korea, Republic of
University Hospital, Rouen

Not yet recruiting

Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ? (S3i)

Irritable Bowel Syndrome

France
National Cancer Institute, Naples
Baxter Healthcare Corporation; Fondazione IRCCS Istituto Nazionale dei Tumori... and other collaborators

Active, not recruiting

A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures (Hemopatch)

Thoracic Surgery Lung | Post-operative Thoracic Air Leak

Italy
Northwestern University

Withdrawn

Evaluation of Hemostatic Agents in Robotic-assisted Laparoscopic Partial Nephrectomy

Renal Malignant Tumor | Robotic-Assisted Laparoscopic Partial Nephrectomy | Hemostatic Agents

United States
Queen's University

Unknown

Evaluation of Bowel Sensitivity Threshold in IBS Patients Versus in Healthy Controls Using the Novel Rapid Barostat Bag

Irritable Bowel Syndrome | Visceral Hypersensitivity

Canada
Tianjin Chasesun Pharmaceutical Co., LTD
Southwest Hospital, China

Completed

Study of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers

Healthy

China
KU Leuven
University Ghent; Vrije Universiteit Brussel; Universiteit Antwerpen; Université...

Terminated

The DAWN Antivirals Trial for Ambulatory COVID-19 Patients (DAWN)

Covid19 | SARS-CoV Infection

Belgium
University Medicine Greifswald
Botiss Medical AG

Terminated

Alveolar Management Following Teeth Extraction

Bone Resorption | Alveolar Bone Loss

Germany
University Hospital, Ghent

Recruiting

The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden

Covid19

Belgium
Eisai Inc.

Completed

Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies

Breast Cancer

United States
Eisai Co., Ltd.

Completed

Study of E7389 for Advanced or Metastatic Breast Cancer

Breast Cancer

Japan
Nanjing First Hospital, Nanjing Medical University

Enrolling by invitation

Mid-and Long-term Efficacy of Ergot Alkaloids in the Treatment of Salivation in Patients With Parkinson's Disease.

Main Heading (Descriptor) Terms

China
Eisai Limited

Completed

QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors

Advanced Solid Tumor

France

Search clinical trials for: Camostat+Mesilate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations